Qualcomm could acquire rival Intel – but securing the deal won't be easy
A tie-up between Qualcomm and its semiconductor rival Intel would be a coup. But multiple regulatory and commercial hurdles lie ahead.
Shares in Intel jumped by 8% last week following reports that chipmaker Qualcomm had approached its struggling rival about a potential takeover, says the Financial Times. A deal is “far from certain” and no formal offer has been made, but a tie-up would eclipse Microsoft’s $69 billion acquisition of Activision as the biggest technology deal on record. Intel’s share price has halved this year, putting the company on the defensive.
Such a deal would be a “massive coup” for Qualcomm, which re-entered the desktop processor market this year as a part of Microsoft’s artificial intelligence (AI) PC strategy after “years of dominance in mobile processors”, say Richard Lawler and Sean Hollister in The Verge.
By contrast, Intel is “arguably in its weakest position in years”, with the company recently announcing big cuts, strategic shifts and a 15% downsizing of its workforce this August after reporting a $1.6 billion loss in the second quarter of 2024. The group later announced that it would spin off its chip-making business, “a part of the company that it had long touted as a strength over rival AMD”.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
What hurdles is Qualcomm facing?
The “yawning gap” between their market values, with Qualcomm worth double Intel’s value, gives Qualcomm an “opening” to pull off a deal, says Bloomberg’s Chris Hughes. It would help Qualcomm diversify its business.
However, many obstacles to a successful transaction remain, not least the fact that neither Intel’s management nor its shareholders will be willing to “play ball” when the share price is “on its knees” unless there is “a very high premium or certain value creation on offer through trading into the enlarged company”. What’s more, asset sales will be required to assuage antitrust regulators – they would probably take place at “fire-sale” prices.
While Qualcomm would probably be required to sell off parts of Intel’s business to deal with antitrust concerns, it would probably also be forced to continue to “shovel ever-more money” into Intel’s manufacturing operations, says Robert Cyran for Breakingviews. These have become a “money pit”, generating $4.2 billion of revenue last quarter but losing $2.8 billion. The US government has made these operations “a cornerstone of its chip strategy, awarding Intel billions in subsidies”. Overall, while Intel’s lower valuation clearly has Qualcomm (and others) “salivating”, this “isn’t the screaming deal it might seem.
Any buyer would need the ability to “solve multiple existential threats” while also “getting such a deal through regulators that would include China”, says Dan Gallagher in The Wall Street Journal. But “questionable deals still have a way of happening”.
No wonder then, that Intel, even in its “current predicament”, is “drawing all types of interest”. For instance, distressed investment specialist Apollo Global Management has offered to buy an equity stake of up to $5 billion, which could be a more plausible scenario than a deal with Qualcomm given Intel’s cash needs and “less likelihood of regulatory hurdles”.
This article was first published in MoneyWeek's magazine. Enjoy exclusive early access to news, opinion and analysis from our team of financial experts with a MoneyWeek subscription.
Related stories
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
Matthew graduated from the University of Durham in 2004; he then gained an MSc, followed by a PhD at the London School of Economics.
He has previously written for a wide range of publications, including the Guardian and the Economist, and also helped to run a newsletter on terrorism. He has spent time at Lehman Brothers, Citigroup and the consultancy Lombard Street Research.
Matthew is the author of Superinvestors: Lessons from the greatest investors in history, published by Harriman House, which has been translated into several languages. His second book, Investing Explained: The Accessible Guide to Building an Investment Portfolio, is published by Kogan Page.
As senior writer, he writes the shares and politics & economics pages, as well as weekly Blowing It and Great Frauds in History columns He also writes a fortnightly reviews page and trading tips, as well as regular cover stories and multi-page investment focus features.
Follow Matthew on Twitter: @DrMatthewPartri
-
Pension warning: one in five don’t know how much is going into their pension
How to check your pension contributions and why it matters
By Katie Williams Published
-
50,000 power of attorney applications rejected – how to avoid common mistakes
A freedom of information request shows that thousands of lasting power of attorney (LPA) applications are rejected due to errors. We explain how to avoid mistakes and reveal tips to make the process as straightforward as possible
By Ruth Emery Published
-
Investing in a dangerous world: key takeaways from the MoneyWeek Summit
If you couldn’t get a ticket to MoneyWeek’s summit, here’s an overview of what you missed
By MoneyWeek Published
-
DCC: a top-notch company going cheap
DCC has a stellar long-term record and promising prospects. It has been unfairly marked down
By Jamie Ward Published
-
How investors can use options to navigate a turbulent world
Explainer Options can be a useful solution for investors to protect and grow their wealth in volatile times.
By James Proudlock Published
-
Invest in Hilton Foods: a tasty UK food supplier
Hilton Foods is a keenly priced opportunity in an unglamorous sector
By Dr Matthew Partridge Published
-
HSBC stocks jump – is its cost-cutting plan already paying off?
HSBC's reorganisation has left questions unanswered, but otherwise the banking sector is in robust health
By Dr Matthew Partridge Published
-
Lock in an 11% yield with Sabre
Tips Sabre, a best-in-class company is undervalued due to low profits in the motor insurance industry. Should you invest?
By Rupert Hargreaves Published
-
Byju’s – the startling rise and fall
India’s educational technology start-up Byju's attracted big-name backers and soared to vertiginous heights during Covid. It has now plummeted. What happened?
By Jane Lewis Published
-
A bull market on borrowed time
While the US enjoys a bull market, it may not last. Will the US rate cut push stock prices down?
By Alex Rankine Published